Ph2/3 study comparing BMS-986504 combined with gem and nab-paclit in pancreatic ductal adeno
Clinical Trial
CA240-0030 - A Randomized Phase 2/3 Study Comparing BMS-986504 Combined with Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion
Participating Locations